IRIS
DE VINCENTIS, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.226
NA - Nord America 536
EU - Europa 339
AF - Africa 15
OC - Oceania 11
SA - Sud America 6
Totale 5.133
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.816
US - Stati Uniti d'America 520
CN - Cina 186
HK - Hong Kong 173
IT - Italia 125
GB - Regno Unito 75
DE - Germania 53
IN - India 20
CZ - Repubblica Ceca 17
NL - Olanda 17
FI - Finlandia 13
CA - Canada 12
FR - Francia 11
AU - Australia 10
TR - Turchia 10
JP - Giappone 8
PT - Portogallo 8
PL - Polonia 6
UA - Ucraina 5
ZA - Sudafrica 5
EG - Egitto 4
KE - Kenya 3
MX - Messico 3
SE - Svezia 3
CL - Cile 2
IR - Iran 2
SA - Arabia Saudita 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
ID - Indonesia 1
IE - Irlanda 1
KI - Kiribati 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MS - Montserrat 1
PE - Perù 1
RS - Serbia 1
SL - Sierra Leone 1
SN - Senegal 1
Totale 5.133
Salva come PNG Salva come JPEG
Città #
Singapore 173
Hong Kong 171
Ashburn 135
Hefei 92
Boardman 90
Rome 65
London 61
Shanghai 58
Munich 33
Los Angeles 22
Council Bluffs 17
Brno 16
Chicago 16
New York 13
San Francisco 13
Amsterdam 12
Pune 11
Turku 11
Washington 10
Santa Clara 9
Seattle 9
Toronto 9
Lisbon 8
Redmond 7
Boydton 6
Guangzhou 6
Paris 6
Tokyo 6
Canberra 5
Milan 5
Warsaw 5
Boston 4
Brooklyn 4
Cairo 4
Kochi 4
Trieste 4
Bedford 3
Dallas 3
Melbourne 3
Mexico City 3
Nairobi 3
Perugia 3
Ascoli Piceno 2
Central 2
Cervignano del Friuli 2
Helsinki 2
Ho Chi Minh City 2
Johannesburg 2
Latina 2
Lubbock 2
Markham 2
Naples 2
New Port Richey 2
Newark 2
Rimini 2
Riyadh 2
Secaucus 2
Stockholm 2
Sydney 2
Taranto 2
Walsall 2
Wembley 2
Ahmedabad 1
Almere Stad 1
Ankara 1
Augusta 1
Bari 1
Belgrade 1
Berlin 1
Budapest 1
Buffalo 1
Camden 1
Campobasso 1
Changchun 1
Charlotte 1
Chengdu 1
Chisinau 1
Cleveland 1
Cold Lake 1
Dakar 1
Denver 1
Dublin 1
Frankfurt am Main 1
Freetown 1
Genoa 1
Gothenburg 1
Haikou 1
Hanover 1
Helena 1
Houston 1
Hyderabad 1
Istanbul 1
Jackson 1
Jinan 1
Las Vegas 1
Lima 1
Manchester 1
Marseille 1
Milwaukee 1
Montpellier 1
Totale 1.216
Salva come PNG Salva come JPEG
Nome #
Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management 201
Chronic cough in adults: recommendations from an Italian intersociety consensus 196
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 193
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 188
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 183
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 179
A Functional and Immunologic Point of View on Corneal Endothelial Transplantation: A Systematic Review and Meta-Analysis 174
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 171
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 170
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 170
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 167
Assessment of liver function by the exhaled breath-print during chronic liver disease 166
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 164
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 121
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 98
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 94
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 93
Orthogeriatric co-management for the care of older subjects with hip fracture: recommendations from an Italian intersociety consensus 90
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 89
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 86
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 82
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 81
A challenging alfa-fetoprotein in a cirrhotic patient 80
Breathprinting of liver diseases 80
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 79
ALT levels are associated with metabolic parameters and age in a large real-life population. 79
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 79
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 79
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 76
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 75
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 74
Return to Sport after Anatomic and Reverse Total Shoulder Arthroplasty in Elderly Patients: A Systematic Review and Meta-Analysis 73
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 72
Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards 71
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 63
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 60
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 50
Essays on quality of therapy and impact of comorbidities in older hospitalized subjects 45
Length of Hospital Stay after Total Knee Arthroplasty: A Correlation Study on 1200 Patients 38
Predicting risk of declining functional ability in community-dwelling older people 29
Return to Sport Activity in the Elderly Patients after Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis 29
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 27
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 27
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 26
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 25
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 25
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 25
Reply 23
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 23
Preoperative and Perioperative Predictors of Length of Hospital Stay after Primary Total Hip Arthroplasty-Our Experience on 743 Cases 23
Screening of obstructive sleep apnea syndrome by electronic-nose analysis of volatile organic compounds 22
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 22
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 21
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 21
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 21
E-nose discriminative ability within a highly homogeneous sample of respiratory diseases 21
Hepatic complications of bariatric surgery : the reverse side of the coin 20
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 20
NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY 20
Neurotrophic keratopathy: pros and cons of current treatments 19
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 19
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 18
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 18
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver 18
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 18
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis 18
Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study 17
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 17
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 17
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 16
Reply 15
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 15
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment 15
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 13
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 13
Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival 13
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 13
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 13
Genetic variants in the MTHFR are not associated with fatty liver disease. 12
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 12
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 11
Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy 9
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 8
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis 7
Clinical outcomes and phenotypes of respiratory failure in older subjects admitted to an acute care geriatric hospital ward 7
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 7
Sleep disorders during the COVID-19 pandemic: Results from the second phase of web-based EPICOVID19 study 6
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 6
The authors reply 6
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 5
Prevalence, clinical characteristics, and disease burden of chronic cough in Italy: a cross-sectional study 4
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 3
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 1
Totale 5.208
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 0 0 10 0 1 4 0 2 54 0 0 103
2022/202399 1 1 8 2 10 4 36 9 5 7 16 0
2023/2024316 11 27 15 36 39 120 0 10 4 16 12 26
2024/20254.616 57 25 87 19 75 96 87 25 217 291 1.633 2.004
2025/20263 3 0 0 0 0 0 0 0 0 0 0 0
Totale 5.208